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Introduction: Major Depression Disorder (MDD) is common among mothers of young children. However,
its detection remains low in primary-care and community-based settings in part due to the uncertainty
regarding the validity of existing case-ﬁnding instruments. We conducted meta-analyses to estimate the
diagnostic validity of commonly used maternal MDD case ﬁnding instruments in the United States.
Methods: We systematically searched three electronic bibliographic databases PubMed, PsycINFO, and
EMBASE from 1994 to 2015 to identify relevant published literature. Study eligibility and quality were
evaluated using the Standards for the Reporting of Diagnostic Accuracy studies and Quality Assessment
of Diagnostic Accuracy Studies guidelines, respectively. Pooled sensitivity and speciﬁcity of case-ﬁnding
instruments were generated using Bayesian hierarchical summary receiver operating models.
Results: Overall, 1130 articles were retrieved and 74 articles were selected for full-text review. Twelve
articles examining six maternal MDD case-ﬁnding instruments met the eligibility criteria and were in-
cluded in our meta-analyses. Pooled sensitivity and speciﬁcity estimates were highest for the BDI-II (91%;
95% Bayesian Credible Interval (BCI): 68%; 99% and 89%; 95% BCI: 62%; 98% respectively) and EPDS10
(74%; 95% BCI: 46%; 91% and 97%; 95% BCI: 84%; 99% respectively) during the antepartum and post-
partum periods respectively.
Limitation: No meta-regression was conducted to examine the impact of study-level characteristics on
the results.
Discussion: Diagnostic performance varied among instruments and between peripartum periods. These
ﬁndings suggest the need for a judicious selection of maternal MDD case-ﬁnding instruments depending
on the study population and target periods of assessment.
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Major depression disorder (MDD) case-ﬁnding instruments rely
on subjective symptoms, patient experiences and perceptions that
are typically validated in the absence of a ‘gold standard’. The
sensitivity and speciﬁcity estimates of these instruments are based
on comparing their classiﬁcation to that of reference standards,
which themselves include classiﬁcation error. Reference standard
errors result in biased case-ﬁnding instrument diagnostic perfor-
mance estimates. Among mothers, during the peripartum period
which includes antepartum and postpartum periods, the potential
for case-ﬁnding instrument misclassiﬁcation error (especially false
positives) is likely to be heightened by the presence of ‘morning
sickness’, ‘baby blues’ and parenting stress symptoms that mimic
those of MDD (Pereira et al., 2014). These issues contribute in part
to the uncertainty regarding how valid existing maternal MDD
case-ﬁnding instruments are in detecting true MDD. As a con-
sequence of this uncertainty, various stakeholders in the United
States (i.e. US Preventive Services Task Force, American Congress of
Obstetricians and Gynecologists, American Academy of Pediatrics,
American Academy of Family Physicians and the American College
of Nurse Midwives) have recommended inconsistent maternal
MDD screening/case-ﬁnding practices and policies (Gaynes et al.,
2005; Agency for Healthcare Research and Quality AHRQ, 2014;
Pignone et al., 2002; O’Connor et al., 2016).
In order to address the uncertainty around the diagnostic va-
lidity of maternal MDD case-ﬁnding instruments, meta-analyses can
be used to generate summary measures of the sensitivity and spe-
ciﬁcity based on studies deemed to be valid and comparable while
maximizing precision estimates. Unfortunately, previous diagnostic
validity systematic reviews of maternal MDD case-ﬁnding instru-
ments have not generated instrument-speciﬁc and/or peripartum
period-speciﬁc pooled sensitivity and speciﬁcity estimates largely
due to variability in not only the populations studied, but also in the
diagnostic thresholds and reference standards used (Gaynes et al.,
2005; Agency for Healthcare Research and Quality AHRQ, 2014;
Pignone et al., 2002; O’Connor et al., 2016). Furthermore, because
both existing maternal MDD case-ﬁnding instruments and re-
ference standards aim to at least partly meet the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
criteria for MDD diagnosis, there could be conditional dependence
in the errors (i.e. false positives and negatives) generated by these
tests when used on the same individuals. Combined, these issues
preclude deﬁnitive conclusions regarding the diagnostic validity of
maternal MDD case-ﬁnding instruments.
Meta-analysis techniques that account and adjust for the above
issues exist; (Sadatsafavi et al., 2010; Chu et al., 2009; Walter et al.,
1999; Dendukuri et al., 2012; Bernatsky et al., 2005; Dendukuri
and Joseph, 2001) however, such methods have not yet been ap-
plied to maternal MDD diagnostic accuracy studies. The objectiveof this study was to conduct meta-analyses to estimate the diag-
nostic validity of commonly used maternal MDD case ﬁnding in-
struments in the US while accounting for 1) varying diagnostic
thresholds, 2) use of multiple imperfect reference standards to
validate the same case-ﬁnding instrument, 3) and the potential for
conditional dependence of errors generated from case-ﬁnding
instrument and reference standard results.2. Methods and procedures
2.1. Data sources and searches
Three electronic databases PubMed, PsycINFO, and EMBASE
were searched for studies published from January 1st, 1994 to
December 31st, 2015. An experienced librarian guided all
searches. Older literature was excluded due to the publication of
the Diagnostic and Statistical Manual of Mental Disorders, Fourth
Edition (DSM-IV) in 1994. Brieﬂy, our search strategy included
various terms for depression, diagnostic performance, and the
names of existing published MDD case-ﬁnding instruments and
reference standards. To identify additional studies, we reviewed
the bibliographies of included articles and previous systematic
reviews.
2.2. Phase I – screening of abstracts
Titles and abstracts of identiﬁed studies were reviewed by Arthur
Owora (AO) for further consideration. AO reviewed all articles
without abstracts in full. Two exclusion criteria were used in
Phase I: (1) no assessment of MDD, and (2) absence of original data.
All articles not meeting these exclusion criteria were reviewed in
Phase II.
2.3. Phase II – review of full articles
Articles moved to Phase II were reviewed in full using the
following eligibility criteria (eTable 1a): MDD measured among
mothers of young children (0–5 years old) in the US and reporting
of both case-ﬁnding and reference standard instrument results.
Articles that included mothers from other countries or mothers
with only older children (45 years) were excluded. Included ar-
ticles were moved to Phase III for a qualitative review and quan-
titative data extraction.
2.4. Phase III – qualitative assessment and quantitative data
extraction
Articles eligible for Phase III were evaluated for their epidemio-
logical quality by two investigators (JR and AO). The investigators
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Diagnostic Accuracy Studies - second version (QUADAS-2) criteria
domains namely: (Whiting et al., 2011) 1) patient selection - three
questions; 2) index test (i.e. case-ﬁnding instruments) – four ques-
tions; 3) reference standard – three questions; 4) ﬂow/timing of as-
sessments – four questions. Two additional signaling questions (not
covered by the QUADAS-2 tool) were added to assess the potential
for confounding and effect modiﬁcation. Here, confounding refers to
the distortion of the relationship between case-ﬁnding instrument
and reference standard results due to a third variable (e.g. age, race,
and peripartum period of assessment) whereas effect modiﬁcation
refers to that relationship changing depending on the levels or ca-
tegories of the third variable. Our study only examined the potential
confounding and effect modiﬁcation effect of peripartum periods. We
were unable to assess the impact of other factors (e.g. age, race) due
to their inconsistent assessment and reporting across studies selected
in Phase III.
Each signaling question was answered by yes/no/unclear and
used to classify the likelihood bias as being low/high/uncertain.
Details of each domain's assessment criteria and overall study
quality ratings are summarized in eTable 1b and 1c, respectively. A
study with a low risk of bias classiﬁcation for all four, three or two
and one or none of QUADAS-2 domains was assigned a ‘good’, ‘fair’
and ‘poor’ overall study quality rating, respectively.
Two investigators (AO and JR) extracted data elements re-
commended by the Standards for Reporting Diagnostic Accuracy
studies (STARD) guidelines (Bossuyt et al., 2003) from all articles
assigned a ‘fair’ or ‘good’ overall study quality rating. The data
elements include the description of the 1) study participants; 2)
study designs; 3) case-ﬁnding instruments and reference stan-
dards; 4) data collection procedures; 5) statistical methods; 6)
contingency tables of the case-ﬁnding instruments compared to
the reference standards used as the ‘Gold Standard’ and reported
as True positives (TP), False Positive (FP), True Negatives (TN) and
False Negatives (FN); 7) how missing and indeterminate results
were handled; and 8) study limitations and external validity. Study
authors were contacted for additional information if needed.
2.5. Statistical analysis
Sensitivity, speciﬁcity, and 95% conﬁdence intervals for each
diagnostic threshold and period of assessment (i.e. antepartum
and postpartum) for case-ﬁnding instruments included in Phase III
were estimated using the Meta-analysis of Diagnostic Accuracy
studies (MADA) package in R 3.1.2 (R Development Core, 2010) (R
Development Core Team, 2015; Philipp Doebler, 2015). Ante-
partum depression was deﬁned as an episode of MDD with onset
occurring during pregnancy. The term ‘episode’ here refers to any
two-week period during which depressive symptoms experienced
by an individual meet DSM-IV MDD diagnostic criteria (Pereira
et al., 2014). Postpartum depression was deﬁned as an episode of
MDD with the onset of symptoms occurring after childbirth
(range: 1–14 months).
Systematic patterns in scatter plots of sensitivity and speciﬁcity
estimates were examined to identify study population characteristics
that inﬂuence instrument diagnostic performance. We examined
four study participant characteristics namely the peripartum period
of assessment; the trimester of pregnancy; the month of postpartum
assessments and the prevalence of MDD and six instrument char-
acteristics including the overall study quality rating; self-report ver-
sus provider reports; number of question items; the reference stan-
dard used; the diagnostic thresholds; and the type of diagnostic
threshold (i.e. standard or optimal). A systematic pattern in a scatter
plot was deﬁned as a predictable variation in sensitivity values as
values of speciﬁcity changed based on any of the investigated par-
ticipant and/or instrument characteristics.As per best practice guidelines, (Higgins and Thompson, 2002;
Rutter and Gatsonis, 2001; Tosteson and Begg, 1988; Littenberg
and Moses, 1993) meta-analyses were conducted only if three or
more independent study samples with diagnostic performance
values for the same instrument were available. The potential for
study heterogeneity (i.e. more variation in instrument-speciﬁc
sensitivity and speciﬁcity estimates than would be expected by
chance alone) was assessed visually using scatter plots and forest
plots. The small number of included studies and their respective
sample sizes made the use of I2 statistic and Cochran Q statistic
tests for homogeneity not reliable, (Higgins and Thompson, 2002;
Rutter and Gatsonis, 2001; Tosteson and Begg, 1988; Littenberg
and Moses, 1993) and therefore these tests were not used.
2.6. Bayesian hierarchical summary receiver operating curve
(HSROC) model
The pooled sensitivity and speciﬁcity of each case-ﬁnding in-
strument were generated using an adapted Bayesian hierarchical
summary receiver operating (HSROC) model proposed by Dendu-
kuri et al. (2012). This Bayesian HSROC model is an adaptation of
the Rutter and Gatsonis (Rutter and Gatsonis, 2001) HSROC model
that accounts for the variation in the sensitivity and speciﬁcity es-
timates of the same instrument due to the use of different diag-
nostic thresholds; the conditional dependence of errors generated
from case-ﬁnding and reference standard results; the use of im-
perfect reference standards and; the use of different reference
standards across studies. Technical details of this model are pro-
vided elsewhere (Dendukuri et al., 2012; Bernatsky et al., 2005;
Dendukuri and Joseph, 2001).
Three sets of summary diagnostic performance estimates (i.e.
antepartum, postpartum and the combined periods where possi-
ble) were generated for each case-ﬁnding instrument from two
different Bayesian HSROC models.
Model A assumed conditional independence and the use of
perfect reference standards. Conditional independence implies
that conditional on the true MDD status of a participant, knowl-
edge of the case-ﬁnding instrument result provides no informa-
tion on the likelihood of the reference standard to be positive and
vice versa.
Model B accounted for the conditional dependence and re-
ference standard misclassiﬁcation error. Conditional dependence
implies that conditional on the true MDD status of a participant,
knowledge of a case-ﬁnding instrument result inﬂuences the
likelihood of the reference standard result to be positive (and vice
versa) since they are both based on the same DSM-IV diagnostic
classiﬁcation criteria. Informative priors estimates of reference
standard diagnostic performance used in Model B were based on
results from expert panel validation studies (Ramirez Basco et al.,
2000; Mitchell and Coyne, 2010; Miller et al., 2001).
Informative priors are a key part of Bayesian inference that
represent information about an uncertain parameter (in our case
the sensitivity and speciﬁcity estimates of reference standards)
that is combined with the probability distribution of new data (TP,
TN, FP, and FN) to yield a posterior distribution of pooled case-
ﬁnding instrument sensitivity and speciﬁcity estimates from
which summary estimates (i.e. median and 95% Bayesian Credible
Intervals [BCI]) are estimated.
Reference standards examined for prior information included:
Structured Clinical Interview of DSM Disorders (sensitivity range:
84–92%; speciﬁcity range: 91–98%), World Health Organization
Composite International Diagnostic Interview (sensitivity range:
94–98%; speciﬁcity range: 72–79%), Schedule for Affective Dis-
orders and Schizophrenia (sensitivity range: 74–84%; speciﬁcity
range: 96–100%), and Diagnostic Interview Schedule (sensitivity
range: 79–96%; speciﬁcity range: 90–98%). Two Bayesian HSROC
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each case-ﬁnding instrument and each peripartum period where
possible using PROC MCMC in SAS (SAS Institute., 2009).3. Results
3.1. Flow of included studies
A total of 1130 non-duplicated studies were identiﬁed through
the search strategy, of which 70 (6%) were eligible for review in
Phase II (Fig. 1). An additional four articles were identiﬁed from
previous systematic reviews and moved to Phase II. Of the 74 ar-
ticles reviewed in full in Phase II, 60 were excluded primarily due
to the study of a non-eligible population (54 studies or 90%). Data
on 21 MDD case-ﬁnding instruments reported in 14 eligible arti-
cles were retrieved in Phase III.
Data from the remaining 14 articles (19% of those read in full)
containing sensitivity and speciﬁcity estimates of 21 different
MDD case-ﬁnding instruments were extracted for potential meta-
analysis. The diagnostic performance of six instruments (29% of
the 21 instruments identiﬁed) namely the Edinburg Postnatal
Depression Scale (EPDS10), (Ji et al., 2011; Tandon et al., 2012;
Yonkers et al., 2009; Hanusa et al., 2008; Beck and Gable, 2001;
Logsdon and Myers, 2010; O'Hara et al., 2012; Venkatesh et al.,
2014; Chaudron et al., 2010) the Beck Depression Inventory ver-
sion II (BDI-II), (Ji et al., 2011; Beck and Gable, 2001; O'Hara et al.,Potentially relevant study titles/abstracts identified
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A.H. Owora et al. / Journal of Affective Disorders 205 (2016) 335–343 339PHQ9, HDRS17 and HDRS21) had an average reading level (i.e. 6th
to 9th reading level). Only four studies (Tandon et al., 2012;
Logsdon and Myers, 2010; Beck and Gable, 2001; Chaudron et al.,
2010) (33%) had a good overall rating of study quality; the rest
(eight) had a fair study quality rating (Ji et al., 2011; Sidebottom
et al., 2012; Yonkers et al., 2009; Hanusa et al., 2008; Davis et al.,
2013; O'Hara et al., 2012; Gjerdingen et al., 2009; Venkatesh et al.,
2014).
3.3. Assessment for heterogeneity
The scatter and forest plots suggested a considerable level of
heterogeneity among studies. Therefore, Bayesian HRSOC models
that account for between study heterogeneity were used to pool
sensitivity and speciﬁcity estimates. Additionally, for two case-
ﬁnding instruments examined in each peripartum-speciﬁc period
(EPDS10 and BDI-II), there was a pattern of higher diagnostic
performance during the antepartum than in the postpartum per-
iod. This suggested that the peripartum period modiﬁed the di-
agnostic performance results, and therefore, we examined study
results within and across peripartum periods. Details of the ana-
lyses and results are provided elsewhere (Owora et al. 2016).
3.4. Comparisons between meta-analysis models across case-ﬁnding
instruments
Compared to models adjusting for the conditional dependence
of errors and reference standard misclassiﬁcation error, the mod-
els assuming conditional independence and perfect reference
standards systematically resulted in lower estimates of diagnostic
performance for all six instruments (Table 2).
3.5. Diagnostic performance of the EPDS10
The EPDS10 was examined in eight studies with diagnostic
thresholds ranging from 10 to 17 (Ji et al., 2011; Tandon et al.,
2012; Yonkers et al., 2009; Hanusa et al., 2008; Beck and Gable,
2001; Logsdon and Myers, 2010; Venkatesh et al., 2014; Chaudron
et al., 2010). Fig. 2 shows the HSROC plot of the EPDS10 sensitivity
and speciﬁcity estimates based on 11 distinct study samples.
Study-speciﬁc sensitivity and speciﬁcity estimates ranged from
63% to 94% and 83% to 90%, respectively. After adjusting for con-
ditional dependence of errors and reference standard mis-
classiﬁcation error, the pooled sensitivity and speciﬁcity were 82%
(95%BCI: 50%; 98%) and 91% (95% BCI: 66%; 99%) respectively
during the antepartum period. During the postpartum period,
sensitivity was lower (74%; 95% BCI: 46%; 91%) but speciﬁcity was
slightly higher (97%; 95% BCI: 84%; 99%).
3.6. Diagnostic performance of the BDI-II
Five studies examined the BDI-II across a range of diagnostic
thresholds (12–20) (Ji et al., 2011; Tandon et al., 2012; Beck and
Gable, 2001; O'Hara et al., 2012; Chaudron et al., 2010). Fig. 3
(HSROC plot) shows the study-speciﬁc sensitivity and speciﬁcity
estimates that ranged from 55% to 92% and from 64% to 100%,
respectively. After adjusting for conditional dependence of errors
and reference standard misclassiﬁcation error, the pooled sensi-
tivity and speciﬁcity were 91% (95%BCI: 68%; 99%) and 89% (95%
BCI: 62%; 98%) respectively during the antepartum period. The
postpartum period estimates were less precise with sensitivity at
77% (95% BCI: 39%; 96%) and speciﬁcity at 93% (95% BCI: 53%; 99%).
3.7. Diagnostic performance of the CESD20/R
Fig. 4 shows the HSROC plot of the CESDR (Tandon et al., 2012)
Table 2
Hierarchical summary receiver operating curve pooled sensitivity and speciﬁcity results of commonly used MDD case-ﬁnding instruments among mothers of young children
in the United States.
Instrument Assessment period Pooled sensitivity (95% BCI) Pooled speciﬁcity (95% BCI)
Model A Model B Model A Model B
CESD20/R Across Peripartum 0.84 (0.61, 0.94) 0.90 (0.51, 0.99) 0.78 (0.48, 0.93) 0.80 (0.42, 0.98)
EPDS10 Antepartum 0.72 (0.59, 0.82) 0.82 (0.50, 0.98) 0.83(0.81, 0.86) 0.91 (0.66, 0.99)
EPDS10 Postpartum 0.68 (0.52, 0.81) 0.74(0.46, 0.91) 0.91 (0.81, 0.96) 0.97(0.84, 0.99)
EPDS10 Across Peripartum 0.67 (0.59, 0.77) 0.77 (0.54, 0.91) 0.89 (0.82, 0.94) 0.96 (0.87, 1.00)
BDI-II Antepartum 0.84 (0.70, 0.93) 0.91 (0.68, 0.99) 0.81 (0.68, 0.90) 0.89 (0.62, 0.98)
BDI-II Postpartum 0.69 (0.62, 0.76) 0.77(0.39, 0.96) 0.81 (0.77, 0.85) 0.93 (0.53, 0.99)
BDI-II Across Peripartum 0.72 (0.67, 0.77) 0.86 (0.68, 0.97) 0.81 (0.78, 0.84) 0.92 (0.75, 0.98)
PHQ9 Across Peripartum 0.83 (0.78, 0.86) 0.92 (0.68, 0.99) 0.79 (0.64, 0.88) 0.79 (0.46, 0.91)
HDRS17 Antepartum 0.89 (0.82, 0.94) 0.97 (0.76, 1.00) 0.73 (0.67, 0.79) 0.78 (0.49, 0.94)
HDRS21 Antepartum 0.79 (0.70, 0.86) 0.85 (0.49, 0.98) 0.81 (0.75, 0.86) 0.89 (0.58, 0.99)
Model A: Bayesian HSROC effects model assuming conditional independence between case-ﬁnding instrument and reference standard test errors and perfect reference
standards.
Model B: Bayesian HSROC Model adjusted for reference standard misclassiﬁcation error and conditional dependence between case-ﬁnding instrument and reference
standard test errors.
Fig. 2. Hierarchical Summary Receiver Operator Curve (HSROC) plot for the
EPDS10. Each open triangle represents each study in the meta-analysis. The curve is
the regression line that summarizes the overall diagnostic accuracy. The pooled
sensitivity and speciﬁcity estimate is based on the assumption of conditional in-
dependence and use of perfect reference standards.
Fig. 3. Hierarchical Summary Receiver Operator Curve (HSROC) plot for the BDI-II.
Each open triangle represents each study in the meta-analysis. The curve is the
regression line that summarizes the overall diagnostic accuracy. The pooled sen-
sitivity and speciﬁcity estimate is based on the assumption of conditional in-
dependence and use of perfect reference standards.
Fig. 4. Hierarchical Summary Receiver Operator Curve (HSROC) plot for the
CESD20/R. Each open triangle represents each study in the meta-analysis. The
curve is the regression line that summarizes the overall diagnostic accuracy. The
pooled sensitivity and speciﬁcity estimate is based on the assumption of condi-
tional independence and use of perfect reference standards.
A.H. Owora et al. / Journal of Affective Disorders 205 (2016) 335–343340and CESD20 (Logsdon and Myers, 2010) sensitivity and speciﬁcity
estimates based on three distinct study samples. One study ex-
amined diagnostic performance of the CESDR (diagnostic thresh-
old: 21 and 22) in both the antepartum and postpartum periodswhile the other study assessed the CESD20 (diagnostic threshold:
16) during the postpartum period. Study-speciﬁc sensitivity esti-
mates ranged from 68% to 88% and speciﬁcity ranged from 51% to
88%. Assuming perfect versus imperfect reference standards
seemed to result in less uncertainty for the pooled speciﬁcity es-
timate but sensitivity estimates were not different (Table 2).3.8. Diagnostic performance of the PHQ9
Four studies (Sidebottom et al., 2012; Hanusa et al., 2008; Davis
et al., 2013; Gjerdingen et al., 2009) were included in the meta-
analysis of PHQ9 (Fig. 5) at a diagnostic threshold of 10. Study-
speciﬁc sensitivity estimates ranged from 32% to 85% and speciﬁ-
city ranged from 9% to 84%. After excluding Hanusa et al., (Hanusa
et al., 2008) a study with a small sample size (29 participants) and
outlier diagnostic performance estimates (i.e. observations that lie
outside the general distribution of observed diagnostic perfor-
mance estimates – see eTable 3 [greater than a 50% difference
when compared to other study estimates of speciﬁcity]), there was
overlap in the 95% BCIs of both the pooled sensitivity and speci-
ﬁcity estimates when assuming perfect versus imperfect reference
standards (Table 2).
Fig. 5. Hierarchical Summary Receiver Operator Curve (HSROC) plot for the PHQ9.
Each open triangle represents each study in the meta-analysis. The curve is the
regression line that summarizes the overall diagnostic accuracy. The pooled sen-
sitivity and speciﬁcity estimate is based on the assumption of conditional in-
dependence and use of perfect reference standards.
Fig. 6. a. Hierarchical Summary Receiver Operator Curve (HSROC) plot for the
HDRS17. Each open triangle represents each study in the meta-analysis. The curve
is the regression line that summarizes the overall diagnostic accuracy. The pooled
sensitivity and speciﬁcity estimate is based on the assumption of conditional in-
dependence and use of perfect reference standards. b. Hierarchical Summary Re-
ceiver Operator Curve (HSROC) plot for the HDRS21. Each open triangle represents
each study in the meta-analysis. The curve is the regression line that summarizes
the overall diagnostic accuracy. The pooled sensitivity and speciﬁcity estimate is
based on the assumption of conditional independence and use of perfect reference
standards.
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One study provided sensitivity and speciﬁcity data for the
HDRS17 and HDRS21 across a range of diagnostic thresholds (15
and 16–22 respectively) (Ji et al., 2011). There was no evidence of
variation in sensitivity and speciﬁcity estimates across three tri-
mesters as shown in Figs. 6a and b. HDRS17 sensitivity estimates
ranged from 66% to 76% and speciﬁcity ranged from 78% to 88%.
The HDRS21 had a slightly higher range of sensitivity estimates
(70% to 81%) but similar speciﬁcity (78% to 88%). Additionally, no
distributional differences were observed between summary diag-
nostic estimates generated under assumptions of perfect versus
imperfect reference standards (Table 2).
3.10. Comparisons across peripartum periods (combined antepartum
and postpartum period studies)
Comparisons across peripartum periods were possible for the
EPDS10, BDI-II, CESD20/R, and PHQ9. After adjusting for the con-
ditional dependence of errors and reference standard mis-
classiﬁcation error, the PHQ9 had the highest pooled sensitivity
estimates (92%; 95%BCI: 68%; 97%) followed by the CESD20/R
(90%; 95% BCI: 51%; 99%), both the EPDS10 and BDI-II had pooled
median estimates below 90%. The EPDS10 had the highest speci-
ﬁcity estimate (96% ; 95%BCI: 87%; 100%) closely followed by BDI-II
(92%; 95% BCI: 75%; 98%). Both the CESD20/R and PHQ9 had
pooled median estimates at or below 80%.4. Discussion
This is the ﬁrst study to estimate the overall diagnostic per-
formance of MDD case-ﬁnding instruments used among mothers
of young children using a Bayesian Meta-analytical approach that
accounts for varying diagnostic thresholds, use of multiple im-
perfect reference standards to validate the same case-ﬁnding in-
strument and the potential for conditional dependence of errors
generated from case-ﬁnding instrument and reference standard
results. In addition to these issues, previous attempts to carry out
such analyses were limited by the lack of enough studies (i.e. less
than three comparable studies) examining the same case-ﬁnding
instrument (Gaynes et al., 2005; Agency for Healthcare Research
and Quality AHRQ, 2014; Pignone et al., 2002; O’Connor et al.,
2016; Gibson et al., 2009). As a consequence, these previous sys-
tematic reviews only provided a qualitative synthesis of thediagnostic performance of maternal MDD case-ﬁnding instru-
ments (Gaynes et al., 2005; Agency for Healthcare Research and
Quality AHRQ, 2014; Pignone et al., 2002; O’Connor et al., 2016;
Gibson et al., 2009).
Our results suggest that maternal MDD case ﬁnding instru-
ments have modest to high diagnostic performance across peri-
partum periods. MDD case ﬁnding instruments tended to show
better sensitivity but worse speciﬁcity during the antepartum
period while the opposite was true during the postpartum period.
Results also show that failure to adjust for the above issues can
substantially underestimate pooled sensitivity and speciﬁcity es-
timates and standard errors.
It is, therefore, plausible that previous meta-analysis estimates
from general population diagnostic accuracy studies (Mulrow
et al., 1995; Manea et al., 2015) were underestimated because they
did not account for the methodological issues described above. For
example, Mulrow et al., (Mulrow et al., 1995) using a linear ran-
dom-effects model, found that the summary diagnostic perfor-
mance of nine different case-ﬁnding instruments assessed in 18
primary-care based studies were modest at best with an overall
sensitivity (84%; 95%CI: 79%; 89%) and speciﬁcity (72%; 95%CI:
67%; 77%). Using similar meta-analysis methods, pooled diagnostic
performance estimates of seven studies showed that the PHQ9 had
low sensitivity (55%; 95%CI: 39%; 73%) but high speciﬁcity (96%;
A.H. Owora et al. / Journal of Affective Disorders 205 (2016) 335–34334295%CI: 94%; 98%) (Manea et al., 2015). Clearly, these estimates are
lower than those observed in our results before and after adjust-
ment for conditional dependence of errors and reference standard
misclassiﬁcation error. Moreover, detection of MDD is expected to
be more straight-forward in the general populations examined
than among mothers of young children further supporting our
suspicion of underestimated diagnostic performance results in
previous meta-analysis studies.
Our meta-analysis represents a comprehensive evaluation of
the diagnostic performance of MDD case-ﬁnding instruments used
among mothers of young children in the US. Study selection,
quality review and data extraction were conducted independently
by two reviewers and disagreements were resolved by discussion/
consensus. Quantitative analyses were performed in accordance
with published guidelines (Rutter and Gatsonis, 2001; Tosteson
and Begg, 1988; Littenberg and Moses, 1993; Deeks, 2001; Ma-
caskill et al., 2010; Reitsma et al., 2009; Trikalinos and Balion,
2012). The Bayesian hierarchical models implemented for the
summary of diagnostic performance adjusted for issues (described
above) ignored in previous general population meta-analysis stu-
dies (Mulrow et al., 1995; Manea et al., 2015). Our HSROC models
also accounted for the use of different reference standards with
varying diagnostic performance across different diagnostic accu-
racy studies, a feature commonly encountered in the absence of
gold standards for the diagnosis of health outcomes based on a
patient's subjective experiences and perceptions of illness (Sa-
datsafavi et al., 2010; Chu et al., 2009; Walter et al., 1999; Den-
dukuri et al., 2012).
Despite these merits, this study has some limitations. For ex-
ample, it was not possible to investigate how and to what extent
patient characteristics (e.g. maternal age, race/ethnicity) and
methodological issues (e.g. selection bias) may have affected study
results due to the small number of studies examining each in-
vestigated instrument. As more MDD diagnostic accuracy studies
among mothers of young children become available, meta-re-
gression analyses that investigate the impact of these factors on
summary diagnostic performance estimates are needed.
In summary, commonly used maternal MDD case-ﬁnding in-
struments in the US were found to have modest to high summary
diagnostic performance that varied across instruments depending
on the peripartum period of assessment. The variations in the
summary diagnostic performance across instruments and peri-
partum speciﬁc periods point to the need for judicious decision
making regarding which instruments should be used for maternal
MDD case-ﬁnding depending on what tradeoffs may be acceptable
as an opportunity cost (missing cases or incorrect diagnosis). Our
results suggest the BDI-II and EPDS10 could be used to mitigate
such costs in the antepartum and postpartum periods respectively.
However, future research should quantify the costs associated
with such tradeoffs to better inform decisions regarding the most
cost-effective case-ﬁnding instruments in each speciﬁc peripartum
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